Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well, hello to you too...Rawnoc. I supposed that that is a challenge? :)
Here you go Detonate: http://www.nasdaqtrader.com/Trader.aspx?id=TradingHaltSearch
You do need to type in "NNVC" then "Search." Please note Halt Time, Resumption Quote Time, and Reason Code.
Halt Date Halt Time Issue Symbol Reason Code
02/11/2014 13:01:22 NNVC T3
02/11/2014 13:01:22 NNVC T2
02/11/2014 13:01:22 NNVC T1
Resumption Date Resumption Quote Time
02/11/2014 13:36:07 NNVC
Trade Halt Code Trade Halt Description
T1 Halt - News Pending
Trading is halted pending the release of material news.
T2 Halt - News Released
The news has begun the dissemination process through a Regulation FD compliant method(s).
T3 News and Resumption Times
The news has been fully disseminated through a Regulation FD compliant method(s); or NASDAQ has determined either that system misuse or malfunction that caused extraordinary market activity will no longer have a material effect on the market for the security or that system misuse or malfunction is not the cause of the extraordinary market activity; or NASDAQ has determined the conditions which led to a halt in an Exchange-Traded Fund are no longer present. Two times will be displayed: (1) the time when market participants can enter quotations, followed by (2) the time the security will be released for trading. All trade halt and resumption times will be posted in HH:MM:SS format.
NNVC Summary Update: 4/6/2014
As stated before, please feel free to add your information to this. Some of you are very knowledgeable! This should be a collective effort.
"Healthcare Heroes" by BusinessNewHaven 2014, a business journal publication that serves the state of Connecticut.
http://www.conntact.com/health/16132-healthcare-heroes-business-new-haven-2014.html
It has an interesting article on Diwan, so I thought I share this. It can help you profile the key player in the company decision making process. You don’t hear much about him or the other patent holders. Usually it’s just Seymour.
Patents:
US: http://patentscope.wipo.int/search/en/WO2009011702
Australia and the Philippines:
(1) http://pericles.ipaustralia.gov.au/ols/auspat/quickSearch.do?queryString=allexcel&resultsPerPage=
(2) http://www.heraldonline.com/2014/03/24/5798625/nanoviricides-inc-announces-issuance.html?sp=/100/773/385/
Europe: http://is.gd/crQJX --not yet, but in progress. (When you read this site, keep this in mind: What does A1, A2, A3 and B stand for after a European publication number? When a European patent application is published together with the search report, it is known as an A1 publication. When this application is published without the search report, it is an A2 document. The search report is then published later as an A3 document. When the patent is granted, it is published as a B document.)
Financials, Licenses, Disclosures, etc…:
http://www.sec.gov/cgi-bin/browse-edgar?company=nanoviricides&owner=exclude&action=getcompany
THERACOUR-NANOVIRICIDES LICENSE AGREEMENT Sept 1, 2005
http://www.sec.gov/Archives/edgar/data/1379006/000114420406047712/v057372_ex10-6.htm
THERACOUR-NANOVIRICIDES LICENSE AGREEMENT Feb 15, 2010.
http://www.sec.gov/Archives/edgar/data/1379006/000114036110007767/ex10_1.htm
How Nanoviricides Works
Please refer to http://www.nanoviricides.com for more details. You should NOT be investing in this stock if you don’t even know what it does! But it has been called the “antibiotic for virus.” Basically, 75 trillion nanoviricides =1 shot/teaspoon; functional cure = 1 shot/month, for 3 months.
For even more details, look at: NanoViricides’ Anti-Virus Technology Published in Bionanotechnology II: Global Prospects or read the patent descriptions.
http://www.businesswire.com/news/home/20111024005430/en/NanoViricides%E2%80%99-Anti-Virus-Technology-Published-Bionanotechnology-II-Global#.UxVv8cuPIqg
Frequently Asked Questions about the FDA Drug Approval Process
http://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm279676.htm
How long does the drug approval process take?
A: The 1992 Prescription Drug User Fee Act (PDUFA) established a two-tiered system – Standard Review and Priority Review.
(1) Standard Review is applied to a drug that offers at most, only minor improvement over existing marketed therapies. The 2002 amendments to PDUFA set a 10 month goal for a standard review.
(2) Priority Review designation is given to drugs that offer major advances in treatment, or provide a treatment where none existed. The goal for completing a Priority Review is six months.
Drug and Device Development Processes:
http://www.patientnetwork.fda.gov/learn-how-drugs-devices-get-approved
Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review:
http://www.patientnetwork.fda.gov/node/376
So where is Nanoviricides in this process?
(1) We already know that the FDA has designated Nanoviricides as an “orphan” drug for dengue fever: http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=402313
The technology for Flucide versus Dengucide is similar; there is only slight modification needed in the nanoviricides, thus once the main technology itself is approved, it is much easier to get approval for the rest of the products.
(2) They already started the Tox study.
Once the studies are completed, NNVC will submit an Investigational New Drug application (IND) to the US FDA which will require at least two consistent cGMP batches of the drug, hence they are working on finishing the cGMP plant. http://www.nanoviricides.com/2014-ceo-letter.pdf
(3) They will also need a Biologic License Application (BLA) -- Biological products are approved for marketing under the provisions of the Public Health Service Act. The Act requires a firm who manufactures a biologic for sale in interstate commerce to hold a license for the product. A biologics license application is a submission that contains specific information on the manufacturing processes, chemistry, pharmacology, clinical pharmacology and the medical affects of the biologic product. If the information provided meets FDA requirements, the application is approved and a license is issued allowing the firm to market the product. [This is not something that NNVC tells you, this is something that I know needs to be done. Do your research!]
Finally Tim Cote is helping them through all of this
Dr. Tim Cote´ of Cote´ Orphan Consulting (COC), who is a former Director of the Office of Orphan Products Development, is helping NNVC with its drug application. In fact, the FDA is still listing him as a director on its website.
Sources:
http://www.fda.gov/aboutfda/transparency/basics/ucm195647.htm
http://finance.yahoo.com/news/nanoviricides-reports-denguecide-orphan-drug-110000071.html
http://coteorphan.com/the-coc-team/
I am actually not here because of the money...
I am on this board because some short sellers are trying to sabotage the company. I am here because of the technology. My family and friends, I am sure yours as well, NEED this technology. Like I said, when the short sellers are touching my #1 priority (my family and friends) they got a fight!
Time and money????? Who cares...? If my family and friends can't live...how am I or them going to enjoy money? :)
drkazmd65,
My background range from genetic engineering, accounting, to real estate and construction. I was doing R&D when a business admin guy came into the lab and was telling my boss what to do...I didn't like it, so I expanded my knowledge. I plan on having my own company someday, but to me, TIME is still my 2nd most valuable resource. First is my family and those that I consider close friends, and then money is last, so my priority is in that order. Money is nice but my time is more precious because you can never buy time. That business concept would have to be worth my time.
But I haven't lost in any of my biotech pick yet. What usually happens is that they get acquired. If it was a public company I would continue to make money. If it was acquired by a private company, my stock stops making money. In either case, I still make money, just not as much in some instances.
Good luck to you as well!
When you have experience you start to get a sense of what the market is doing, but most importantly, YOUR investing behaviors and realized that when we make decision in an emotional state, we often make poor decisions.
From my experience, especially with High Frequency Trading (HFT), there's no way as an individual investor that I'll be able to beat HFT. They will make 1000X more money than me because they are microseconds ahead of us individual investors. But by recognizing my weakness, I realized that if I do my research, SOLID research, get the stock ahead of time, NOT during, or when it happens, or after it happens--because by then, it's just too late! The darn HFT beat me to it!
My strength, on the other hand is my ability to analyze information and persevere/delayed gratification when the there is false information or for the product/investments to mature. I always keep extra cash on hand to purchase more stock when the stock dips down.
In order to make money in the stocks markets, we have to understand our strength and weaknesses.
Good Morning to you too Crossbone09!
I started my morning with watering my garden. And now I am looking over the cGMP pictures: http://www.nanoviricides.com/sheltonfacility.html#prettyPhoto
Anyway, hope everyone has a nice day!
Thank you for being knowledgeable Dr. Seldon!
Here's the link for the orphan designation of NNVC: http://www.accessdata.fda.gov/scripts/opdlisting/oopd/OOPD_Results_2.cfm?Index_Number=402313
In terms of time frame and incentives:
-7-year marketing exclusivity to the first sponsor obtaining FDA approval of a designated drug
-Tax credit equal to 50% of clinical investigation expenses
- Exemption/Waiver of application (filing) fees (PDUFA)
- Assistance in drug development process
- Orphan Products Grant funding
From my experience....over 20+ years....all of the companies that I've made over 4000+ % can flat line for 3-7 years, or very little movement and then suddenly, they skyrocketed. If you didn't purchase prior to the skyrocketed/bull, you missed out, that was TSLA (flatlined for 3 years) and AXDX (10yr flatline). I was in on both of those stocks and by the time people caught up, they also tried to short the stock because it was VERY expensive, but they ended up with a short squeeze instead. How much profit is AXDX worth if you purchased it at $1.85/share and it's now worth $22? 1189% and there's more to grow! Here's the catch, most people, including me, are not good at predicting when the breakout point occurs and the stock skyrocket. If you don't have the stock by the time frame, you lose out. Most people jump in after the fact, and sure they made money, but NOT much.
I was looking at the Institutional Holdings today:
http://www.nasdaq.com/symbol/nnvc/institutional-holdings
There were 2 pages of institutional holders, including Goldman Sachs. They were dying to get into NNVC stock in 2013. You can see purchases in December 31, 2013 because finally NNVC was listed on the NYSE.
What's more interesting is that despite all the so-called BAD news to drive down the price so that some people can cover their short position in NNVC, there is NOT one change in the institutional holders position.
Here's the advantage that you guys got as individual investors: institutional investors could NOT invest in pennies stocks. That's why NNVC is no longer a penny stock and the institutional investors are happy to jump aboard. So if you bought NNVC when it was a penny stock: keep it! I know that some people would like to drive down the price of the stock so that it is less than $2 with false rumors, but you do know the NYSE will HALT the stock at a certain price point, right? Not to mention that unethical manipulation of the stock market could get you in SERIOUS legal trouble.
NOT only some of what short sellers are doing is somewhat unethical...but when you missed...ouch! It really is BIG. Not to mentioned, that by trying to drive the price down with false rumors so that you guys can buy the stock cheaper to cover your short position...borrowing something that you don't own and then trying to pay it back is really NOT a good way to invest.
http://www.nasdaq.com/symbol/nnvc/short-interest
You REALLY got a problem if you've been shorting the stock. Anyway, for any misleading info you put out there, I might be tempted to CORRECT the misleading information. :)
That was interesting. But did anyone also read this in the CEO letter:
It's 1 shot/month for 3 months. My fault.
NNVC Summary
(BK and Dr. Shelton, this should be a JOIN effort at info collection. Feel free to add to this as well. You both had some well written info, but unfortunately, I am short on time to search for your posts). Most of you guys are thinking national, but I would like to point out the international implication as well as the large scale production that is needed. In the international arena, it could go much faster. That's why I've stated that everything is depending on the completion of the cGMP plant. Once that is done everything will fall into place quickly.
"2014 Researcher of the Year" by BusinessNewHaven, a business journal publications that serve the state of Connecticut.
http://www.conntact.com/health/16132-healthcare-heroes-business-new-haven-2014.html
It has an interesting article on Diwan, so I thought I share this. You don’t hear much about him or the other patent holders. Usually it’s just Seymour.
Patents:
US: http://patentscope.wipo.int/search/en/WO2009011702
Australia and the Philippines:
http://www.heraldonline.com/2014/03/24/5798625/nanoviricides-inc-announces-issuance.html?sp=/100/773/385/
Europe: http://is.gd/crQJX --not yet, but in process. (When you read this site, keep this in mind: What does A1, A2, A3 and B stand for after a European publication number? When a European patent application is published together with the search report, it is known as an A1 publication. When this application is published without the search report, it is an A2 document. The search report is then published later as an A3 document. When the patent is granted, it is published as a B document.)
How Nanoviricides Works
Please refer to http://www.nanoviricides.com for more details. But basically, 75 trillion nanoviricides/teaspoon = 1 shot; functional cure = 1 shot for 3 months.
For evern more details, look at: NanoViricides’ Anti-Virus Technology Published in Bionanotechnology II: Global Prospects or read the patent descriptions.
http://www.businesswire.com/news/home/20111024005430/en/NanoViricides%E2%80%99-Anti-Virus-Technology-Published-Bionanotechnology-II-Global#.UxVv8cuPIqg
Frequently Asked Questions about the FDA Drug Approval Process
http://www.fda.gov/Drugs/ResourcesForYou/SpecialFeatures/ucm279676.htm
How long does the drug approval process take?
A: The 1992 Prescription Drug User Fee Act (PDUFA) established a two-tiered system – Standard Review and Priority Review.
(1) Standard Review is applied to a drug that offers at most, only minor improvement over existing marketed therapies. The 2002 amendments to PDUFA set a 10 month goal for a standard review.
(2) Priority Review designation is given to drugs that offer major advances in treatment, or provide a treatment where none existed. The goal for completing a Priority Review is six months.
NNVC will need this (hence cGMP plant):
Biologic License Application (BLA) -- Biological products are approved for marketing under the provisions of the Public Health Service Act. The Act requires a firm who manufactures a biologic for sale in interstate commerce to hold a license for the product. A biologics license application is a submission that contains specific information on the manufacturing processes, chemistry, pharmacology, clinical pharmacology and the medical affects of the biologic product. If the information provided meets FDA requirements, the application is approved and a license is issued allowing the firm to market the product.
Drug and Device Development Processes:
http://www.patientnetwork.fda.gov/learn-how-drugs-devices-get-approved
Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review:
http://www.patientnetwork.fda.gov/node/376
Finally Tim Cote is helping them through all of this
Dr. Tim Cote´ of Cote´ Orphan Consulting (COC), who is a former Director of the Office of Orphan Products Development, is helping NNVC with its drug application. In fact, the FDA is still listing him as a director on its website.
Please refer to the following website for my sources:
http://www.fda.gov/aboutfda/transparency/basics/ucm195647.htm
http://finance.yahoo.com/news/nanoviricides-reports-denguecide-orphan-drug-110000071.html
http://coteorphan.com/the-coc-team/
That is EXCELLENT BigKahuna!
May I add that 75 trillion nanoviricides/teaspoon or shot; functional cure = 1 shot for 3 months.
Dr. Tim Cote´ of Cote´ Orphan Consulting (COC), who is a former Director of the Office of Orphan Products Development, is helping NNVC with its drug application.
In fact, the FDA is still listing Dr. Tim Cote´ as a director on its website.
Please refer to the following websites for sources:
http://www.fda.gov/aboutfda/transparency/basics/ucm195647.htm
http://finance.yahoo.com/news/nanoviricides-reports-denguecide-orphan-drug-110000071.html
http://coteorphan.com/the-coc-team/
Anyway,I am done with the arguments for the day. I really do have things that I need to do.
I really don't know, but from my experience there are scientists who like to do the research. They don't want to deal with business and sales and marketing, and ....wellll....all THIS PR stuff. They prefer to get a royalty from the research end of things and leave it to the people who wants to deal with the business portion.
That does't mean that they are STUPID. They know enough to protect themselves.
Leifsmith wrote: Theracour is protecting themselves in case of an NNVC failure. I don't think they expect a failure, but it is a smart thing to do. Whatever happens they want to keep a grip on that right to manufacture, but that doesn't mean they are not prepared to negotiate an arrangement that extends the right to someone else, limited, of course, by performance stipulations.
Business can be more than battling attorneys struggling to gain advantage by torturing the words of an agreement that was once entered into in good faith by all parties.
That I DO agree with you, and the reason has to do the other two patent holders, besides Diwan. There's a total of 3 people that the patent is register to.
IT's really easy to check if the stock is "halt."
http://www.nasdaqtrader.com/Trader.aspx?id=TradingHaltSearch
<laugh> But have you ALWAYS been right?
Chances are, you missed some...:)
BigKahuhna wrote:
Quote:
What could be simpler than the following?
I attended Columbia and Baylor and graduated from Baylor in 1965
In medicine, being licensed, there is no way to falsify credentials
Checked by too many agencies
Great! It would to nice to see header and date, but you know that this only proves my point, right?
He always says that he went to Columbia Univeristy. Why is that "sketchy?"
I guess, what I am trying to say is that in order to prove me wrong you need to prove that what Seymour says is "sketchy" by proving that he contradicted himself on two separate occasions, or the he did NOT go to Columbia University. Teri Buhl claimed that he didn't because she received a letter from the Columbia. But we have not seen such a letter. I am suggesting that it's simpler to CALL Columbia University and verify this.
Gene Seymour cites both Columbia and Baylor on his linkedin page, and in each case he shows that he was pursuing an MD. He moved from Columbia to Baylor and got the degree from Baylor. I have no problem with this. My source for the information is a personal communication from Seymour. I trust him on this.
Was this in an email that you can attach to your post?
Rawnoc says: IThink, your research only supports the claim that there is something sketchy about how how Dr. Seymoir represents hi education. Wasn't there similar questions about Dr. Mennon attending Harvard.
My research did not support the idea that something is "sketchy" about how Dr. Seymour represents his education. My research supported the idea that there is clearly something WRONG with Teri Buhl's article about Dr. Seymour.
Also, do not confuse the facility with the Tox. The company an CEO have repeatedly stated that they will use material from existing facility for production of Tox material. Of course this was after stating it would e from the new facility, then there was a delay, so they would use the existing facility, then they needed to scale up at existing, then they needed to divert production from flucide Tox material for dengue or Ebola or h7n5, do you see the pattern?
I HAVE the articles. They're using the existing facility to START the production of Tox material. It's just to get it started. In that sense, they are managing their time well. Multi-tasking, while waiting. They can't possibly complete the study using the existing facility. It's NOT possible. They have to meet Quality Assurance and Standards requirements.
And if you don't, and are as research driven as you claim, I urge you to look at this board from the past 6 years. Search Tox in '11, '12, '13...you'll see that this isn't simply "they've been slower than I would have liked."
I understand that I have NOT been on this board for that long, but I've been researching the company since 2008. So I know what the company actually said and DIDN'T. I keep copies, of what was said, dates and everything. What this board has proven to me is that there are members who posts things that are not necessarily "accurate" or "precise" and that some people on this board is "shorting" the stocks of certain companies, and intentionally driving the prices down. But I will look at this board previous postings. I am "fair."
Leifsmith says: Gene Seymour himself says he did not receive his degree from Columbia.
And like I said, WHERE is your FACT to back this up?
This is Eugene Seymour LinkedIn profile:
http://www.linkedin.com/pub/eugene-seymour-md-mph/5/303/63
(1) Eerrr...he DIDN'T lie about his education? :)
(2) If you're referring to this article: http://seekingalpha.com/article/2010691-nanoviricides-house-of-cards-with-minus-80-percent-downside-strong-sell-recommendation
Specifically this quote in the article: NNVC's CEO Eugene Seymour on RedChip (RedChip is famous for promoting multiple China frauds)
Well, RedChip is a company that tries to search for penny stocks, period. There are lots of penny stocks that RedChip promotes, fraud or not. Just goto www.redchip.com
Did you call Levi & Korsinsky? Their phone is: (877)363-5972.
The ONE thing that I DO agree with you Rawnoc is that the whole process so far is SLOW. I will give you that. I am as impatient as the next person; however, do realize that Dr. Tim Coté of Coté Orphan Consulting (COC), who is still listed as Director of the Office of Orphan Products Development with the FDA is working with NNVC:
(1) http://www.fda.gov/aboutfda/transparency/basics/ucm195647.htm
(2) http://finance.yahoo.com/news/nanoviricides-reports-denguecide-orphan-drug-110000071.html
Right now, everything is contingent on the cGMP production plant. That's the break-through. Once that is finish, things will move a lot faster. But NNVC needs that plant up and going. The delays has been terrible for the company. They should have planned better, but they DIDN'T. They could have expedited this, but they didn't because they don't understand the whole construction process as well as they think.
I am the same way when it comes to con artists. So I understand, but I am FACTUAL. I NEED that letter from Shaquoia Garo or Columbia University that says he never attended school there for it to convince me. Your link as far as I am concern is not sufficient. I believe the information that I have because I did the research myself. I made copies of Dr. Seymour bios prior to Teri Buhl article with dates and everything....so I KNOW what was and was not there. What I DO know is that I do NOT trust Teri Buhl information because it's NOT true.
You guys need to do your own research, not be speculating. I like it here because you do have interesting info that I need, or do not have, but I go through the info that you guys provide me and have it verified.
I have a trust issue. :)
About this Teri Buhl..I read the article that she wrote when it first came out. I have a HUGE problem with it:
(1) “Shaquoia Garo, from Columbia University-College of Physician and Surgeons, confirms in an email NanoViricides cofounder Eugene Seymour did not receive a medical degree from the University.”
I would like see a copy of this so-called letter from Shaquoia Garo. I supposed that we could call her. BUT…
(2) “When the news first showed up as a possible allegation on Seeking Alpha today the company took down it’s website at the 3pm hour while trading in the stock was still going on. The company bio was edited today and the NanoVircides website was back online after the market closed. Where Seymour got his medical training is now a vague line on his bio.”
This is INCORRECT. How do I know? I have COPIES of his bios on the website PRIOR to this year, say, at least 2 years prior. It goes something like (There were two separate ones over the years):
Ok. You guys are driving me nuts! All you have to do is pick up the phone and call the law company.
Be factual not stupid! Give credit where credit is due; no more and no less than that.
It is a good post and most of what you said is correct. But from my experience that I've had of one specific company that had been around for over 20+ years making millions and the CEO was well-known and a prominent member of our state and I went to work for them. It took me less than 2 months to figure out that there was something funny with the accounting. I had quit a few weeks after that. But during the time that I was working there, there was a team of auditors doing audit and they didn't catch anything. The company because bankrupt within 4 years after. FBI was involved, etc...
Like I've said before, accounting is VERY important.
That being said, I really do like the technology. They do have a patent on it.
There is a lot of short interest on this stock. The days to cover is 4.599840 but we'll see later on today if that has changed: http://www.nasdaq.com/symbol/nnvc/short-interest
I didn't use it with the quotation marks. I had put the quotation marks on it to say that that's the specific link that I was using. It was the nanoviricides website. The link wasn't working then, but it is working now. They must of be doing some sort of maintenance.
Here's the case: http://www.docstoc.com/docs/document-preview.aspx?doc_id=166597866&key=undefined&pass=undefined
You can read it for yourself and determine it's validity.
Basically, if I have to sum it up, they are suing for conflict of interest.
I can't seem to find this CEO letter on the Nanoviricides website. Where is this CEO letter? Can anyone provide a link. The one that I tried last time DOESN'T work.
Where's the letter to the stockholders? I can't find it. That link doesn't work.
Leifsmith wrote:"For more, read Dr. Seymour's letter to stockholders, March 10, 2014:
http://www.nanoviricides.com/2014-ceo-letter.pdf"
Since you guys helped me out yesterday, I am throwing you guys something.
This is the docket for the case in Colorado. It's not dead, but here's the link so that you can keep up with what's going on: http://dockets.justia.com/docket/colorado/codce/1:2013cv01777/141766/
Thank you!
Is no one concern that NNVC Financials are "Unaudited"?
I've been following your posts in here. Some of you have addressed some interesting topics, mostly the first two parts of my research: technology and management.
For me, when I invest, I look at 3 things: technology, management, and financials.
Technology: most of you who follows NNVC closely is impressed with the studies so far with the animal tests.
Management: most of you are saying there's probably some sort of "conflict of interest" and as you know when you have this many law firms looking at NNVC, it usually will take them about a month to collect and then file a complaint. So maybe we will hear someone filing a complaint about this in mid or late March?
Financials: I am really concerned about the "unaudited" part as you know. How come none of you have mentioned this issue? Are you simply not concerned? I find that odd. www.sec.gov/Archives/edgar/data/1379006/000114420414009813/v367879_10q.htm